173 related articles for article (PubMed ID: 28192244)
21. The clinicopathological and prognostic value of programmed death-ligand 1 in colorectal cancer: a meta-analysis.
Ni X; Sun X; Wang D; Chen Y; Zhang Y; Li W; Wang L; Suo J
Clin Transl Oncol; 2019 May; 21(5):674-686. PubMed ID: 30392153
[TBL] [Abstract][Full Text] [Related]
22. Log odds of positive lymph nodes as a novel prognostic predictor for colorectal cancer: a systematic review and meta-analysis.
Li Y; Wu G; Zhang Y; Han B; Yang W; Wang X; Duan L; Niu L; Chen J; Zhou W; Liu J; Fan D; Hong L
BMC Cancer; 2022 Mar; 22(1):290. PubMed ID: 35303818
[TBL] [Abstract][Full Text] [Related]
23. Association between the overexpression of Her3 and clinical pathology and prognosis of colorectal cancer: A meta-analysis.
Yan Q; Guo K; Feng G; Shan F; Sun L; Zhang K; Shen F; Shen M; Ruan S
Medicine (Baltimore); 2018 Sep; 97(37):e12317. PubMed ID: 30212974
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological and prognostic value of S100A4 expression in non-small cell lung cancer: a meta-analysis.
Zhang J; Gu Y; Liu X; Rao X; Huang G; Ouyang Y
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32696952
[TBL] [Abstract][Full Text] [Related]
25. The prognostic value of abnormally expressed lncRNAs in colorectal cancer: A meta-analysis.
Wang J; Du S; Wang J; Fan W; Wang P; Zhang Z; Xu P; Tang S; Deng Q; Yang W; Yu M
PLoS One; 2017; 12(6):e0179670. PubMed ID: 28658310
[TBL] [Abstract][Full Text] [Related]
26. The Role of p-STAT3 as a Prognostic and Clinicopathological Marker in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Ji K; Zhang M; Chu Q; Gan Y; Ren H; Zhang L; Wang L; Li X; Wang W
PLoS One; 2016; 11(8):e0160125. PubMed ID: 27504822
[TBL] [Abstract][Full Text] [Related]
27. Prognostic role of the lymph node ratio in node positive colorectal cancer: a meta-analysis.
Zhang MR; Xie TH; Chi JL; Li Y; Yang L; Yu YY; Sun XF; Zhou ZG
Oncotarget; 2016 Nov; 7(45):72898-72907. PubMed ID: 27662659
[TBL] [Abstract][Full Text] [Related]
28. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
29. The significant prognostic value of circulating tumor cells in colorectal cancer: A systematic review and meta-analysis.
Tan Y; Wu H
Curr Probl Cancer; 2018; 42(1):95-106. PubMed ID: 29277243
[TBL] [Abstract][Full Text] [Related]
30. Expression of ZNF148 in different developing stages of colorectal cancer and its prognostic value: a large Chinese study based on tissue microarray.
Gao XH; Liu QZ; Chang W; Xu XD; Du Y; Han Y; Liu Y; Yu ZQ; Zuo ZG; Xing JJ; Cao G; Fu CG
Cancer; 2013 Jun; 119(12):2212-22. PubMed ID: 23576061
[TBL] [Abstract][Full Text] [Related]
31. Is Ep-CAM Expression a Diagnostic and Prognostic Biomarker for Colorectal Cancer? A Systematic Meta-Analysis.
Han S; Zong S; Shi Q; Li H; Liu S; Yang W; Li W; Hou F
EBioMedicine; 2017 Jun; 20():61-69. PubMed ID: 28558958
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
[TBL] [Abstract][Full Text] [Related]
33. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
Yang C; Zou K; Zheng L; Xiong B
BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
[TBL] [Abstract][Full Text] [Related]
34. The prognostic value of survivin expression in patients with colorectal carcinoma: a meta-analysis.
Huang YJ; Qi WX; He AN; Sun YJ; Shen Z; Yao Y
Jpn J Clin Oncol; 2013 Oct; 43(10):988-95. PubMed ID: 23894202
[TBL] [Abstract][Full Text] [Related]
35. Claudin-1 Is a Valuable Prognostic Biomarker in Colorectal Cancer: A Meta-Analysis.
Zuo D; Zhang J; Liu T; Li C; Ning G
Gastroenterol Res Pract; 2020; 2020():4258035. PubMed ID: 32855635
[TBL] [Abstract][Full Text] [Related]
36. Low expression of claudin-1 and presence of poorly-differentiated tumor clusters correlate with poor prognosis in colorectal cancer.
Shibutani M; Noda E; Maeda K; Nagahara H; Ohtani H; Hirakawa K
Anticancer Res; 2013 Aug; 33(8):3301-6. PubMed ID: 23898096
[TBL] [Abstract][Full Text] [Related]
37. Prognostic role and clinicopathological features of SMAD4 gene mutation in colorectal cancer: a systematic review and meta-analysis.
Fang T; Liang T; Wang Y; Wu H; Liu S; Xie L; Liang J; Wang C; Tan Y
BMC Gastroenterol; 2021 Jul; 21(1):297. PubMed ID: 34301194
[TBL] [Abstract][Full Text] [Related]
38. Loss of claudin-1 expression induces epithelial-mesenchymal transition through nuclear factor-κB activation in colorectal cancer.
Kim NY; Pyo JS; Kang DW; Yoo SM
Pathol Res Pract; 2019 Mar; 215(3):580-585. PubMed ID: 30683478
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Significance and Diagnostic Value of Overexpressed lncRNA PVT1 in Colorectal Cancer.
Pan X; Cheng R; Zhu X; Cai F; Zheng G; Li J; Gao C
Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850702
[TBL] [Abstract][Full Text] [Related]
40. TYMS serves as a prognostic indicator to predict the lymph node metastasis in Chinese patients with colorectal cancer.
Lu Y; Zhuo C; Cui B; Liu Z; Zhou P; Lu Y; Wang B
Clin Biochem; 2013 Oct; 46(15):1478-83. PubMed ID: 23810585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
